NCT07520942Completed
TECAR and ESWT in Obesity-Related Lower Limb Lymphedema
The Effect of TECAR Therapy and Extracorporeal Shock Wave Therapy Combined With Complex Decongestive Therapy in the Treatment of Bilateral Lower-Limb Secondary Lymphedema in Severely Obese Patients: A Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 9 Apr 2026
Brief summary (registry, in English)
This randomized controlled trial evaluates the effectiveness of adding TECAR therapy or extracorporeal shock wave therapy (ESWT) to complex decongestive therapy (CDT) in the treatment of bilateral lower-limb lymphedema in severely obese patients. Forty-five female participants were randomly assigned to one of three groups: CDT alone, CDT combined with TECAR, or CDT combined with ESWT. The interventions were applied over a four-week period. The primary outcome was reduction in limb circumference, while secondary outcomes included quality of life, pain intensity, and tissue stiffness. Assessments were conducted at baseline, after 4 weeks of treatment, and at 8 weeks follow-up.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 45 (actual)
- First submitted
- 3 Apr 2026
- Start date
- 25 Oct 2025
- Primary completion date
- 6 Feb 2026
- Lead sponsor
- Applied Science Private University
- Diseases
- Obesity
- NCT number
- NCT07520942
What you commit to
- Study type: Interventional
- Participants enrolled: 45
- From 25 Oct 2025 to the primary completion date, 6 Feb 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Contraindications to ESWT or TECAR therapy including pacemaker or implanted electronic devices
- Patients receiving concurrent lymphedema treatment or those who had received intensive treatment within the preceding 3 months
Other illness
- Secondary lymphedema due to malignancy, radiation, surgery, or infection
- Acute deep vein thrombosis or history of recurrent thrombosis
- Active infection or cellulitis
- Peripheral arterial disease with ankle-brachial index below 0.8
- Uncontrolled cardiac failure or renal insufficiency
Other
- Primary lymphedema
- Pregnancy or lactation
Who the study is looking for
- Female patients aged 18-75 years with bilateral lower limb lymphedema secondary to severe obesity (BMI ≥40 kg/m²)
- Lymphedema duration of at least 3 months
- Clinical diagnosis confirmed by an experienced lymphedema specialist with bilateral limb swelling (pitting or non-pitting edema extending above the ankle)
- Ability to attend treatment sessions five times weekly for 4 weeks and follow-up assessments
Age in the registry: 18 years to 75 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Modawah Physical Therapy Center Coordinator of this site? Confirm its status | Banī Suwayf | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.